Drug-Induced Lung Injury / edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
Contributor(s): SpringerLink (Online service)
| Hanaoka, Masayuki, editor literario | Nakamura, Hiroyuki, editor literario
| Aoshiba, Kazutetsu, editor literario
Material type:
E-bookSeries: (Respiratory Disease Series: Diagnostic Tools and Disease Managements, 2509-5552); (Medicine (Springer-11650)).Publisher: Singapore : Springer International Publishing, 2018Description: 1 recurso en línea (VIII, 215 páginas 53 ilustraciones, 15 ilustraciones a color).ISBN: 9789811044663.Subject: Pulmones -- Enfermedades
| Item type | Current library | Collection | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Madrid Digital Acceso Electrónico (UEM) | Ciencias de la Salud | RD539 .D784 2018 EB (Browse shelf(Opens below)) | Acceso electrónico | eBook.08112138 |
Part I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.
There are no comments on this title.